Cost-Effectiveness of Pembrolizumab Versus Ipilimumab in Ipilimumab-Naïve Patients with Advanced Melanoma in the United States

Title
Cost-Effectiveness of Pembrolizumab Versus Ipilimumab in Ipilimumab-Naïve Patients with Advanced Melanoma in the United States
Authors
Keywords
-
Journal
Journal of Managed Care & Specialty Pharmacy
Volume 23, Issue 2, Pages 184-194
Publisher
Academy of Managed Care Pharmacy
Online
2017-01-27
DOI
10.18553/jmcp.2017.23.2.184

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now